SCHEMBL31076194

SCHEMBL31076194

Cc1ccc2ccc3ccc(CO)c4ccc1c2c34

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
TSHR P16473 2/20 0.55
HPGD P15428 2/20 0.55
HSD17B10 Q99714 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
CYP3A4 P08684 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 5/20 0.36
CYP2A6 P11509 3/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
MAPT P10636 1/20 0.33
ACHE P22303 1/20 0.33
SLC6A2 P23975 1/20 0.33
AHR P35869 1/20 0.33
KDM4E B2RXH2 3/20 0.33
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31076421 1.00 ALDH1A1 (0.55) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL14639099 1.00 ALDH1A1 (0.55) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL6586507 0.87 KMT2A (0.44) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL6584885 0.87 KMT2A (0.44) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL16250698 0.80 ALDH1A1 (0.80) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL505806 0.79 KMT2A (0.56) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL29397724 0.79 KMT2A (0.56) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL29503684 0.79 KMT2A (0.56) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL22005816 0.77 ALDH1A1 (0.52) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL14638674 0.76 MEN1 (0.38) ALDH1A1HPGDHSD17B10L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024177860-A1 IN CHEMICO TEST FOR TOXICITY LEBRUN LABS LLC (US) 2024-08-29 WO claimed
US-12559784-B2 In chemico test for toxicity LEBRUN LABS LLC (US) 2026-02-24 US disclosed
US-20250369032-A1 IN CHEMICO TEST FOR TOXICITY LEBRUN LABS LLC (US) 2025-12-04 US disclosed
US-20250101489-A1 IN CHEMICO TEST FOR TOXICITY LEBRUN LABS LLC 2025-03-27 US disclosed
WO-2024177860-A1 IN CHEMICO TEST FOR TOXICITY LEBRUN LABS LLC (US) 2024-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559784-B2 In chemico test for toxicity ALPP, ALPI, CUTA ALDH1A1 274/4885TSHR 556/4885HPGD 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.